CURX stock news · Curanex Pharmaceuticals
Get alerts for CURX
Follow Curanex Pharmaceuticals (CURX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CURXFree on the App Store and Google Play, or on the web.
Curanex Pharmaceuticals showed no sales and a bigger loss in the third quarter of 2026.
Bad for CURXCuranex's operating loss grew to $2.82 million from $0.95 million, and its loss per share widened to $1.86 from $0.75. This points to a weaker outlook.